Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

vertex pharmaceuticals incorporated

POPULAR ARTICLES

Vertex Announces New Drug Submission for Suzetrigine Has Been Accepted for Review by Health Canada for the Treatment of Moderate-to-Severe Acute Pain in Adults

Vertex Announces New Drug Submission for Suzetrigine Has Been Accepted for Review by Health Canada for the Treatment of Moderate-to-Severe Acute Pain in Adults

Vertex to Participate in Upcoming May Investor Conferences

Vertex to Participate in Upcoming May Investor Conferences

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany

LATEST ARTICLES

Vertex Reports First Quarter 2026 Financial Results

Vertex Reports First Quarter 2026 Financial Results

Vertex to Announce First Quarter 2026 Financial Results on May 4th

Vertex to Announce First Quarter 2026 Financial Results on May 4th

Vertex to Announce First Quarter 2026 Financial Results on May 4th

Vertex to Announce First Quarter 2026 Financial Results on May 4th

Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States

Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States

Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy

Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy

Vertex to Participate in Upcoming March Investor Conferences

Vertex to Participate in Upcoming March Investor Conferences

Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures

Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures

Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3

Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3

Vertex Reports Fourth Quarter and Full Year 2025 Financial Results

Vertex Reports Fourth Quarter and Full Year 2025 Financial Results

Latest News

Further Extension of Rights Issue Closing Date

Early Warning Report and News Release Regarding Securities of Silver Hammer Mining Corp.

Positive Magnetic Study Results at Pioneer Tungsten Project

Tenement Application Expands Newmans Rare Earth Target Area

Alvopetro Announces Q2 2026 Dividend of US$0.12 Per Share and Initial 183-D1 Well Results

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Jameson Resources

Jameson Resources (JAL:AU)

JAL:AU

Skyharbour Resources

Skyharbour Resources (SYH:CC)

SYH:CC

Ni-Co Energy

Ni-Co Energy (None)

Freegold Ventures

Freegold Ventures (FVL:CC)

FVL:CC

West High Yield

West High Yield (WHY:CC)

WHY:CC

Quebec Innovative Materials

QIMC:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES